Table 1.
Comparison of control, IV-, and PO-infected groups
| Group | Subject | Gender | Age of SIV infection | Age at euthanasia | Total infection period | Plasma SIV RNA (copies/mL)a |
|---|---|---|---|---|---|---|
| IV-infected | RM1 | M | 1 week | 10 weeks | 9 weeks | 160,000,000 |
| IV-infected | RM2 | F | 1 week | 7 weeks | 6 weeks | 240,000,000 |
| IV-infected | RM3 | F | 1 week | 10 weeks | 10 weeks | 650,000,000 |
| PO-infected | RM4 | F | 9 weeks | 21 weeks | 12 weeks | 5,800,000 |
| PO-infected | RM5 | F | 17 weeks | 27 weeks | 10 weeks | 6,400,000 |
| PO-infected | RM6 | F | 10 weeks | 22 weeks | 12 weeks | 380,000 |
| PO-infected | RM7 | F | 13 weeks | 25 weeks | 12 weeks | 46,000,000 |
| PO-infected | RM8 | M | 9 weeks | 21 weeks | 12 weeks | 71,000,000 |
| Control | RM9 | F | N/A | 16 weeks | N/A | N/A |
| Control | RM10 | M | N/A | 16 weeks | N/A | N/A |
| Control | RM11 | F | N/A | 15 weeks | N/A | N/A |
| Control | RM12 | F | N/A | 16 weeks | N/A | N/A |